SCHEMBL4932649

SCHEMBL4932649

COc1ccc(CCN(Cc2ccc(C=CC(=O)NO)cc2)C(=O)NC(=O)c2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
LMNA P02545 1/20 0.53
HDAC1 Q13547 13/20 0.52
HDAC2 Q92769 8/20 0.52
HDAC3 O15379 6/20 0.52
HDAC8 Q9BY41 6/20 0.52
BCHE P06276 1/20 0.52
ACHE P22303 1/20 0.52
HDAC6 Q9UBN7 8/20 0.51
LPAR1 Q92633 1/20 0.51
LPAR5 Q9H1C0 1/20 0.51
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
HDAC4 P56524 4/20 0.49
HDAC7 Q8WUI4 4/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4932644 1.00 ALDH1A1 (0.53) ALDH1A1MEN1KMT2ALMNAHDAC1
SCHEMBL4930171 0.92 HDAC1 (0.51) ALDH1A1MEN1KMT2ALMNAHDAC1
SCHEMBL4930166 0.92 HDAC1 (0.51) ALDH1A1MEN1KMT2ALMNAHDAC1
SCHEMBL4933474 0.91 HDAC1 (0.57) HDAC1HDAC2HDAC3HDAC8HDAC6
SCHEMBL4933463 0.91 HDAC1 (0.57) HDAC1HDAC2HDAC3HDAC8HDAC6
SCHEMBL4922675 0.88 HDAC1 (0.52) LMNAHDAC1HDAC2HDAC3HDAC8
SCHEMBL8291642 0.88 HDAC1 (0.53) HDAC1HDAC2HDAC3HDAC8HDAC6
SCHEMBL4930160 0.88 HDAC2 (0.53) HDAC1HDAC2HDAC3HDAC8HDAC6
SCHEMBL4930156 0.88 HDAC2 (0.53) HDAC1HDAC2HDAC3HDAC8HDAC6
SCHEMBL4922668 0.88 HDAC1 (0.52) LMNAHDAC1HDAC2HDAC3HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates S*BIO PTE LTD. (SG) 2008-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates HDAC1, HDAC3, HDAC4 ALDH1A1 1020/4885MEN1 2737/4885KMT2A 105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.